These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25599952)

  • 1. Synthesis, radiolabeling and evaluation of novel 4-oxo-quinoline derivatives as PET tracers for imaging cannabinoid type 2 receptor.
    Slavik R; Herde AM; Bieri D; Weber M; Schibli R; Krämer SD; Ametamey SM; Mu L
    Eur J Med Chem; 2015 Mar; 92():554-64. PubMed ID: 25599952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2.
    Slavik R; Müller Herde A; Haider A; Krämer SD; Weber M; Schibli R; Ametamey SM; Mu L
    J Neurochem; 2016 Sep; 138(6):874-86. PubMed ID: 27385045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of novel PET tracers for imaging cannabinoid receptor type 2 in brain.
    Slavik R; Bieri D; Cermak S; Müller A; Krämer SD; Weber M; Schibli R; Ametamey SM; Mu L
    Chimia (Aarau); 2014; 68(4):208-10. PubMed ID: 24983598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor.
    Mu L; Bieri D; Slavik R; Drandarov K; Müller A; Cermak S; Weber M; Schibli R; Krämer SD; Ametamey SM
    J Neurochem; 2013 Sep; 126(5):616-24. PubMed ID: 23795580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of carbon-11- and fluorine-18-labeled 2-oxoquinoline derivatives for type 2 cannabinoid receptor positron emission tomography imaging.
    Evens N; Muccioli GG; Houbrechts N; Lambert DM; Verbruggen AM; Van Laere K; Bormans GM
    Nucl Med Biol; 2009 May; 36(4):455-65. PubMed ID: 19423014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evaluation of the novel radiotracer [
    Meletta R; Slavik R; Mu L; Rancic Z; Borel N; Schibli R; Ametamey SM; Krämer SD; Müller Herde A
    Nucl Med Biol; 2017 Apr; 47():31-43. PubMed ID: 28104528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a high affinity and selective pyridine analog as a potential positron emission tomography imaging agent for cannabinoid type 2 receptor.
    Slavik R; Grether U; Müller Herde A; Gobbi L; Fingerle J; Ullmer C; Krämer SD; Schibli R; Mu L; Ametamey SM
    J Med Chem; 2015 May; 58(10):4266-77. PubMed ID: 25950914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of 4-oxo-quinoline-based CB2 PET radioligands in R6/2 chorea huntington mouse model and human ALS spinal cord tissue.
    Haider A; Spinelli F; Herde AM; Mu B; Keller C; Margelisch M; Weber M; Schibli R; Mu L; Ametamey SM
    Eur J Med Chem; 2018 Feb; 145():746-759. PubMed ID: 29353725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro biological evaluation of carbon-11-labeled quinoline derivatives as new candidate PET radioligands for cannabinoid CB2 receptor imaging.
    Gao M; Wang M; Miller KD; Hutchins GD; Zheng QH
    Bioorg Med Chem; 2010 Mar; 18(6):2099-2106. PubMed ID: 20189815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and preliminary evaluation of [18F]-labeled 2-oxoquinoline derivatives for PET imaging of cannabinoid CB2 receptor.
    Turkman N; Shavrin A; Paolillo V; Yeh HH; Flores L; Soghomonian S; Rabinovich B; Volgin A; Gelovani J; Alauddin M
    Nucl Med Biol; 2012 May; 39(4):593-600. PubMed ID: 22226022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET imaging of cannabinoid type 2 receptors with [
    Pottier G; Gómez-Vallejo V; Padro D; Boisgard R; Dollé F; Llop J; Winkeler A; Martín A
    J Cereb Blood Flow Metab; 2017 Mar; 37(3):1163-1178. PubMed ID: 28079433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors.
    Haider A; Gobbi L; Kretz J; Ullmer C; Brink A; Honer M; Woltering TJ; Muri D; Iding H; Bürkler M; Binder M; Bartelmus C; Knuesel I; Pacher P; Herde AM; Spinelli F; Ahmed H; Atz K; Keller C; Weber M; Schibli R; Mu L; Grether U; Ametamey SM
    J Med Chem; 2020 Sep; 63(18):10287-10306. PubMed ID: 32787079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and preliminary evaluation of (18)F-labelled 1,8-naphthyridin- and quinolin-2-one-3-carboxamide derivatives for PET imaging of CB2 cannabinoid receptor.
    Saccomanni G; Pascali G; Carlo SD; Panetta D; De Simone M; Bertini S; Burchielli S; Digiacomo M; Macchia M; Manera C; Salvadori PA
    Bioorg Med Chem Lett; 2015 Jun; 25(12):2532-5. PubMed ID: 25956416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical evaluation of [11C]NE40, a type 2 cannabinoid receptor PET tracer.
    Evens N; Vandeputte C; Coolen C; Janssen P; Sciot R; Baekelandt V; Verbruggen AM; Debyser Z; Van Laere K; Bormans GM
    Nucl Med Biol; 2012 Apr; 39(3):389-99. PubMed ID: 22154685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Biological Evaluation of Thiophene-Based Cannabinoid Receptor Type 2 Radiotracers for PET Imaging.
    Haider A; Müller Herde A; Slavik R; Weber M; Mugnaini C; Ligresti A; Schibli R; Mu L; Mensah Ametamey S
    Front Neurosci; 2016; 10():350. PubMed ID: 27512365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-Activity Relationship Studies of Pyridine-Based Ligands and Identification of a Fluorinated Derivative for Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors.
    Haider A; Kretz J; Gobbi L; Ahmed H; Atz K; Bürkler M; Bartelmus C; Fingerle J; Guba W; Ullmer C; Honer M; Knuesel I; Weber M; Brink A; Herde AM; Keller C; Schibli R; Mu L; Grether U; Ametamey SM
    J Med Chem; 2019 Dec; 62(24):11165-11181. PubMed ID: 31751140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical evaluation of [
    Attili B; Celen S; Ahamed M; Koole M; Haute CVD; Vanduffel W; Bormans G
    Br J Pharmacol; 2019 May; 176(10):1481-1491. PubMed ID: 30588600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a novel acetamidobenzoxazolone-based PET ligand for translocator protein (18 kDa) imaging of neuroinflammation in the brain.
    Tiwari AK; Yui J; Fujinaga M; Kumata K; Shimoda Y; Yamasaki T; Xie L; Hatori A; Maeda J; Nengaki N; Zhang MR
    J Neurochem; 2014 May; 129(4):712-20. PubMed ID: 24484439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study.
    Yamagishi S; Iga Y; Nakamura M; Takizawa C; Fukumoto D; Kakiuchi T; Nishiyama S; Ohba H; Tsukada H; Sato K; Ouchi Y
    J Neuroinflammation; 2019 Nov; 16(1):208. PubMed ID: 31707986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Labelling and biological evaluation of [(11)C]methoxy-Sch225336: a radioligand for the cannabinoid-type 2 receptor.
    Evens N; Bosier B; Lavey BJ; Kozlowski JA; Vermaelen P; Baudemprez L; Busson R; Lambert DM; Van Laere K; Verbruggen AM; Bormans GM
    Nucl Med Biol; 2008 Oct; 35(7):793-800. PubMed ID: 18848664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.